fbpx

Dr. Gail K. Naughton

Gail Naughton closeupDr. Gail K. Naughton, Ph.D. serves as the Chairman of the Board and Chief Executive Officer at Histogen Aesthetics, LLC. Dr. Naughton founded Histogen, Inc., in 2007 and also has been its Chairman and Chief Executive Officer since June 2007. Dr. Naughton is a pioneer in the field of regenerative medicine. She served as Scientific Advisor at Carmell Therapeutics Corporation. She is a respected Scientist with extensive experience in the field of tissue engineering.

Prior to September 1995, she co-founded Advanced Tissue Sciences Inc., in 1986 and served as its Executive Vice President since June 1991, Chief Operating Officer from June 1991 to 2000, Senior Vice President and Chief Scientific Officer from January 1989 to June 1991, Principal Scientist from 1986 to December 1988, President from September 1995 to March 2002 and Chief Operating Officer from September 1995 to August 2000. She oversaw the design and development of the world’s first up-scaled manufacturing facility for tissue engineered products, established corporate development and marketing partnerships with companies including Smith & Nephew, Ltd., Medtronic and Inamed Corporation.

Dr. Naughton served for more than 15 years at Advanced Tissue Sciences Inc., where she was Co-Inventor of its core technology. She serves as the Head and Member of Scientific Advisory Board of Theregen, Inc. She served as Vice Chairman of the Board at Advanced Tissue Sciences Inc., from March 2002 to October 2002. She has been an Independent Director at CR Bard Inc. since July 2004. She has been a Director of Centre for Commercialization of Regenerative Medicine since January 31, 2014 and Celera Corporation since July 1, 2008 and served as a Director at SYS Technologies, Inc. since August 30, 2004. She serves as a Director of Histogen, Inc., AACSB International, the California Health Institute, the San Diego World Trade Center and the San Diego Corporate Governance Institute.

Dr. Naughton serves as Member of Vascular Advisory Board of Humacyte, Inc. She has been an Advisory Board Member of College of Business Administration Entrepreneurial Management Center of San Diego State University since August 2002. She serves as a Member of the Scientific Advisory Board of Frantz Medical Ventures. She has been Independent Director of Cytori Therapeutics, Inc. since July 1, 2014. She served as a Director of Advanced Tissue Sciences, Inc., since 1986. She served as a Director of CellCeuticals Skin Care, Inc. She serves on the boards of several academic institutions, non-profit organizations and foundations. She serves as a Member of Board of Advisors of Perminova, Inc.

She has been the Dean of College of Business Administration (CBA) at San Diego State University (SDSU) since August 2002. She serves on the Advisory Boards of the Department of Bioengineering at Johns Hopkins University and Georgia Institute of Technology. She serves as a Member of the Industrial Liaison Board at the University of California, San Diego, Georgia Institute of Technology, the Massachusetts Institute of Technology and the University of Washington.

She serves as a Member of the UCSD Connect Leadership Council, the San Diego Science & Technology Council and Rotary International. She serves as a Director of the City of Hope. She serves as a Director of the Charles H. and Anna S. Stern Foundation and the Ackerman Foundation. She serves as a Trustee of the American Society of Artificial Internal Organs (ASAIO). She is a Committee Member of the National Academies Committee on Intellectual Property in the Knowledge-Based Economy.

She held professorships at City University of New York, Hunter College and York College. Dr. Naughton was an Assistant Professor of Research at New York University Medical Center for two years. She discovered the potential of proteins and growth factors produced by newborn fibroblasts for therapeutic and biomedical applications, and developed Histogen’s unique technology process to create products based on these proteins. She holds over 90 U.S. and foreign patents and is extensively published in the field of tissue engineering. In 2000, she received the 27th Annual National Inventor of the Year award in 2000 by the Intellectual Property Owners Association (IPO) in honor of her pioneering work in the field of tissue engineering. She has conducted extensive research and authored numerous scientific publications. Her primary fields of research include cell and tissue culture technology, dermatology and hematology. She served as a Director of Advanced Tissue Sciences, Inc. since 1986.

She served as a Director of DermTech International, Inc. Dr. Naughton earned a B.S. in Biology from St. Francis College, Brooklyn, New York, and both a Master’s degree in Histology in 1978 and a Ph.D. in Hematology from New York University Medical Center in 1981, and completed her Post-doctoral training at New York University Medical Center in the Department of Dermatology. She also holds a Master’s of Business Administration in Executive Management in 2001 from the Anderson School at the University of California, Los Angeles.

 

.